These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32833163)

  • 1. Guideline-directed medical therapy in heart failure patients: impact of focused care provided by a heart failure clinic in comparison to general cardiology out-patient department.
    Joseph J; P S S; James J; Abraham S; Abdullakutty J
    Egypt Heart J; 2020 Aug; 72(1):53. PubMed ID: 32833163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, Safety and Mechanistic Impact of a Heart Failure Guideline-Directed Medical Therapy Clinic.
    Spahillari A; Cohen LP; Lin C; Liu Y; Tringale A; Sheppard KE; Ko C; Khairnar R; Williamson KM; Wasfy JH; Scott NS; Paquette C; Greene SJ; Fonarow GC; Januzzi JL
    JACC Heart Fail; 2024 Oct; ():. PubMed ID: 39387769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Optimization of Guideline-Directed Medical Therapy during Hospitalization among Patients with Heart Failure with Reduced Ejection Fraction in Daily Clinical Practice.
    Bánfi-Bacsárdi F; Muk B; Pilecky D; Duray GZ; Kiss RG; Nyolczas N
    Cardiology; 2023; 148(1):27-37. PubMed ID: 36470212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
    Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients.
    Parajuli DR; Shakib S; Eng-Frost J; McKinnon RA; Caughey GE; Whitehead D
    BMC Cardiovasc Disord; 2021 Feb; 21(1):104. PubMed ID: 33602125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.
    Peri-Okonny PA; Mi X; Khariton Y; Patel KK; Thomas L; Fonarow GC; Sharma PP; Duffy CI; Albert NM; Butler J; Hernandez AF; McCague K; Williams FB; DeVore AD; Patterson JH; Spertus JA
    JACC Heart Fail; 2019 Apr; 7(4):350-358. PubMed ID: 30738978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
    Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS
    Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.
    Greene SJ; Fonarow GC; DeVore AD; Sharma PP; Vaduganathan M; Albert NM; Duffy CI; Hill CL; McCague K; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Butler J
    J Am Coll Cardiol; 2019 May; 73(19):2365-2383. PubMed ID: 30844480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice.
    Smith KV; Dunning JR; Fischer CM; MacLean TE; Bosque-Hamilton JW; Fera LE; Grant JY; Zelle DJ; Matta L; Gaziano TA; MacRae CA; Scirica BM; Desai AS
    J Pharm Pract; 2022 Oct; 35(5):747-751. PubMed ID: 33813934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial.
    Allen LA; Venechuk G; McIlvennan CK; Page RL; Knoepke CE; Helmkamp LJ; Khazanie P; Peterson PN; Pierce K; Harger G; Thompson JS; Dow TJ; Richards L; Huang J; Strader JR; Trinkley KE; Kao DP; Magid DJ; Buttrick PM; Matlock DD
    Circulation; 2021 Feb; 143(5):427-437. PubMed ID: 33201741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.
    Balakumaran K; Patil A; Marsh S; Ingrassia J; Kuo CL; Jacoby DL; Arora S; Soucier R
    Int J Cardiol Heart Vasc; 2019 Mar; 22():1-5. PubMed ID: 30480083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Multidisciplinary Heart Failure Clinic on Guideline-Directed Medical Therapy and Clinical Outcomes.
    Tan SS; Hisham SA; Bin Abdul Malek AM; Lik CP; Lau GSK; Bin Abdul Ghapar AK
    Can J Hosp Pharm; 2024; 77(1):e3364. PubMed ID: 38204512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the Potential of Primary Care Pharmacists to Improve Heart Failure Management.
    Slade J; Lee M; Park J; Liu A; Heidenreich P; Allaudeen N
    Jt Comm J Qual Patient Saf; 2022 Jan; 48(1):25-32. PubMed ID: 34848159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a pharmacist-managed heart failure medication titration clinic.
    Martinez AS; Saef J; Paszczuk A; Bhatt-Chugani H
    Am J Health Syst Pharm; 2013 Jun; 70(12):1070-6. PubMed ID: 23719886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of a multidisciplinary heart failure clinic in optimization of guideline-directed medical therapy: HF-optimize.
    Diederich T; Burdorf A; Pozehl B; Bowman S; Ferguson K; Holder K; Alonso W; Stoller D; Lundgren S
    Heart Lung; 2023; 57():95-101. PubMed ID: 36088681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure medication dosage and survival in women and men seen at outpatient clinics.
    Bots SH; Onland-Moret NC; Tulevski II; van der Harst P; Cramer MJM; Asselbergs FW; Somsen GA; den Ruijter HM
    Heart; 2021 Nov; 107(21):1748-1755. PubMed ID: 34261736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure clinics improve use of evidence-based heart failure therapies in patients with reduced ejection fraction following acute coronary syndrome (ANZACS-QI 48).
    Chan D; Doughty RN; Mazengarb J; McLachlan A; Kerr AJ
    N Z Med J; 2020 Jun; 133(1516):58-71. PubMed ID: 32525862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline-led prescribing to ambulatory heart failure patients in a cardiology outpatient service.
    El Hadidi S; Vaughan C; Kerins D; Byrne S; Darweesh E; Bermingham M
    Int J Clin Pharm; 2021 Aug; 43(4):1082-1089. PubMed ID: 33411177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.